Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Albany Molecular Research Inc. (AMRI) and Icagen, Inc. have signed a collaboration agreement to co-market Icagen's ion channel and transporter technology to global pharmaceutical and biotechnology clients.
read more
Novartis is adding to its diverse and deep immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology. The agreement gives Novartis access to four pre-clinical programs that target regulatory T cell ...
read more
Celerion has announced that effective January 1, 2016, Assign Clinical Research, headquartered in Vienna, Austria, has joined Celerion, further expanding their global presence and capabilities in the conduct of complex early clinical studies.
read more
iCardiac Technologies, Inc., a scientific leader in the conduct of cardiac safety assessments, today announced it is providing industry-wide access to its pivotal dataset as part of an effort announced by the Cardiac Safety Research Consortium to ...
read more
AstraZeneca and Incyte Corporation have announced a new collaboration to evaluate the efficacy and safety of Incyte’sJanus-associated kinase (JAK) 1 inhibitor, INCB39110, in combination with AstraZeneca’s next generation epidermal growth factor ...
read more
Wednesday, January 13, 2016
AMRI has announced the extension of a key insourcing relationship with a major pharmaceutical company designed to accelerate their chemistry and drug discovery efforts.
read more
Wednesday, January 13, 2016
Last year was an exceptionally strong year for biopharmaceutical innovation as the U.S. Food and Drug Administration (FDA) approved 45 new medicines – the highest number of approvals in almost two decades - giving patients even greater hope for the ...
read more
Wednesday, January 13, 2016
Catalent a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products has announced, through its wholly owned subsidiary, Redwood Bioscience, Inc., a research collaboration with Roche...
read more
Wednesday, January 13, 2016
Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has announced the appointment of Eric Murphy, Ph.D., as global scientific director for ...
read more
Wednesday, January 13, 2016
inVentiv Health, a professional services organization that accelerates the clinical and commercial success of biopharmaceutical companies worldwide, today marked the official opening of its new Phase I clinic in the United States, located at the ...
read more
Wednesday, January 13, 2016
ClinTec International has announced the appointment of Dr. Harley Simon, MD, as Chief Medical Officer (CMO) and Executive Vice President (EVP) Client Relations. Dr. Simon is a physician registered in the UK and South Africa with almost 20 years of ...
read more
Thursday, January 14, 2016
Experimental Pathology Laboratories, Inc. (EPL) has acquired Aclairo Pharmaceutical Development Group, Inc. (Aclairo).
read more
Thursday, January 14, 2016
Albany Molecular Research Inc. (AMRI) has signed a collaboration agreement with the New York Center for Nanomedicine Research (NYCNMR) to co-market their nanotechnology services to global pharmaceutical and biotechnology clients.
read more
Thursday, January 14, 2016
Eurofins Scientific has announced the acquisition of Sinensis Life Sciences B.V. a provider of pharmaceutical product testing and cGMP Quality Control (QC) services in the Netherlands.
read more
Thursday, January 14, 2016
Pharm-Olam International Ltd., a clinical research solutions organization to the biopharmaceutical and medical device industries, has announced its expansion of Phase I-IV clinical trial services into the Asia-Pacific region.
read more